Differential diagnosis and prognosis of delayed neuropsychiatric sequelae after acute carbon monoxide poisoning in a patient with schizophrenia: A case report | Canada Hyperbarics Skip to main content
Case Report PCN Rep 2024

Differential diagnosis and prognosis of delayed neuropsychiatric sequelae after acute carbon monoxide poisoning in a patient with schizophrenia: A case report

Satake Y, Mamiya Y, Kano S, Akizuki K, Hashimoto M, Ikeda M — PCN Rep, 2024

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers described the case of a 37-year-old man with schizophrenia who developed delayed neuropsychiatric symptoms after acute carbon monoxide poisoning.

What They Found

A 37-year-old man with schizophrenia developed delayed neuropsychiatric symptoms, including disorganized behaviors and mental decline, around 32 days after carbon monoxide poisoning. An electroencephalogram (EEG) on Day 38 confirmed the diagnosis, after which he received hyperbaric oxygen therapy (HBOT). His condition dramatically improved, and his abnormal EEG findings disappeared by Day 83, with clinical stability maintained for 33 months despite progressive brain changes on MRI.

What This Means for Canadian Patients

This case highlights that delayed neuropsychiatric sequelae (DNS) can occur weeks after carbon monoxide poisoning, even in patients with complex medical histories like schizophrenia. For Canadian patients experiencing similar symptoms after CO exposure, this suggests that HBOT could be an effective treatment option, and that EEG may be a valuable tool for diagnosis.

Canadian Relevance

This study covers carbon monoxide poisoning, which is a Health Canada-recognized indication for hyperbaric oxygen therapy.

Study Limitations

As a single case report, these findings may not apply to all patients with similar conditions.

Was this summary helpful?

Study Details

Study Type Case Report
Category Neurological
Source Pubmed
PubMed ID 38910909
Year Published 2024
Journal PCN Rep

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.